Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis

In idiopathic pulmonary fibrosis (IPF), the fibroblast focus is a key histological feature representing active fibroproliferation. On standard 2D pathologic examination, fibroblast foci are considered small, distinct lesions, although they have been proposed to form a highly interconnected reticulum as the leading edge of a “wave” of fibrosis. Here, we characterized fibroblast focus morphology and interrelationships in 3D using an integrated micro-CT and histological methodology. In 3D, fibroblast foci were morphologically complex structures, with large variations in shape and volume (range, 1.3 × 104 to 9.9 × 107 μm3). Within each tissue sample numerous multiform foci were present, ranging from a minimum of 0.9 per mm3 of lung tissue to a maximum of 11.1 per mm3 of lung tissue. Each focus was an independent structure, and no interconnections were observed. Together, our data indicate that in 3D fibroblast foci form a constellation of heterogeneous structures with large variations in shape and volume, suggesting previously unrecognized plasticity. No evidence of interconnectivity was identified, consistent with the concept that foci represent discrete sites of lung injury and repair.

[1]  H. Russell A modification of Movat's pentachrome stain. , 1972, Archives of pathology.

[2]  Russell Hk,et al.  A modification of Movat's pentachrome stain. , 1972 .

[3]  L. Feldkamp,et al.  Practical cone-beam algorithm , 1984 .

[4]  J. Myers,et al.  Bronchiolitis Obliterans and Usual Interstitial Pneumonia: A Comparative Clinicopathologic Study , 1986, The American journal of surgical pathology.

[5]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  J. Nyengaard,et al.  The number of glomerular capillaries estimated by an unbiased and efficient stereological method , 1993, Journal of microscopy.

[7]  J R Nyengaard,et al.  The Conneulor: unbiased estimation of connectivity using physical disectors under projection. , 1993, Bone.

[8]  K P Whittall,et al.  Quantification of idiopathic pulmonary fibrosis using computed tomography and histology. , 1997, American journal of respiratory and critical care medicine.

[9]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[10]  S. Iyer,et al.  Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. , 1999, The Journal of pharmacology and experimental therapeutics.

[11]  M J Paulus,et al.  High resolution X-ray computed tomography: an emerging tool for small animal cancer research. , 2000, Neoplasia.

[12]  W. Thurlbeck,et al.  Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. , 2001, American journal of respiratory and critical care medicine.

[13]  A. Nicholson,et al.  The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[14]  F. Martinez,et al.  Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. , 2003, American journal of respiratory and critical care medicine.

[15]  T. Rogers Fibroblastic foci in usual interstitial pneumonia. , 2004, American journal of respiratory and critical care medicine.

[16]  Matthias Ochs,et al.  The number of alveoli in the human lung. , 2004, American journal of respiratory and critical care medicine.

[17]  Dianna D Cody,et al.  Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography. , 2006, Academic radiology.

[18]  K. Brown,et al.  Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. , 2006, American journal of respiratory and critical care medicine.

[19]  G Allan Johnson,et al.  A MICRO–COMPUTED TOMOGRAPHY–BASED METHOD FOR THE MEASUREMENT OF PULMONARY COMPLIANCE IN HEALTHY AND BLEOMYCIN–EXPOSED MICE , 2007, Experimental lung research.

[20]  T. Farncombe,et al.  Journal of Translational Medicine Comparison between Conventional and "clinical" Assessment of Experimental Lung Fibrosis , 2008 .

[21]  E. B. Meltzer,et al.  Idiopathic pulmonary fibrosis , 2008, Orphanet journal of rare diseases.

[22]  T. Hartman,et al.  Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. , 2008, Respiratory medicine.

[23]  B. Metscher MicroCT for developmental biology: A versatile tool for high‐contrast 3D imaging at histological resolutions , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  H. Gundersen,et al.  Stereological estimation of the total number of ventilatory units in mice lungs , 2010, Journal of microscopy.

[25]  G. Raghu,et al.  Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology , 2010, European Respiratory Journal.

[26]  Jürgen Borlak,et al.  Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1 , 2010, Respiratory research.

[27]  Stephan Saalfeld,et al.  As-rigid-as-possible mosaicking and serial section registration of large ssTEM datasets , 2010, Bioinform..

[28]  T. Rodt,et al.  Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-b 1 , 2011 .

[29]  Warren B. Gefter,et al.  The n e w e n g l a n d j o u r n a l of m e d i c i n e , 2011 .

[30]  C. Barkauskas,et al.  Pulmonary fibrosis: patterns and perpetrators. , 2012, The Journal of clinical investigation.

[31]  K. Leslie Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. , 2012, Archives of pathology & laboratory medicine.

[32]  M. L. R. D. Christenson,et al.  An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management , 2012 .

[33]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[34]  Uwe Himmelreich,et al.  Quantification of Lung Fibrosis and Emphysema in Mice Using Automated Micro-Computed Tomography , 2012, PloS one.

[35]  Robert Alexander,et al.  Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation , 2013, European Respiratory Journal.

[36]  H. Iwasaki,et al.  Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non‐specific interstitial pneumonia , 2013, Respirology.

[37]  R. Sussman,et al.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[38]  B. Ryffel,et al.  Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[39]  G. Verleden,et al.  The site and nature of airway obstruction after lung transplantation. , 2014, American journal of respiratory and critical care medicine.

[40]  C. Vancheri,et al.  Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  A. Azuma,et al.  A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .

[42]  Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.

[43]  J. Hogg,et al.  Three Dimensional Imaging of Paraffin Embedded Human Lung Tissue Samples by Micro-Computed Tomography , 2015, PloS one.

[44]  V. Thannickal,et al.  Novel Mechanisms for the Antifibrotic Action of Nintedanib. , 2016, American journal of respiratory cell and molecular biology.